Origin Genomics aims to prove that the potential benefits of its technology for editing disease-causing genes in human embryos outweigh the risks.
<iframe src="https://statesidedaily.com/embed/cluster/6a4f148dc373d8d4a62398b6e35cfd37b595b0b7" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="This startup wants to prove gene-editing embryos is safe for making healthy babies"></iframe>
Origin Genomics aims to prove that the potential benefits of its technology for editing disease-causing genes in human embryos outweigh the risks.
